The IL-6 signaling pathway is associated with tumor angiogenesis, and previous studies have found that the suppression of IL-6 signaling led to suppression of angiogenesis and migration of breast cancer (Luo et al., 2020). The gene discussed is IL6; the disease is breast cancer.